The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

LS-48381     1-(4-fluorophenyl)-4-[4- hydroxy-4-[3...

Synonyms: NSC 169875, AC1L27SO, D08637, Triperidol (TN), UNII-UIC8RB6P81, ...
This record was replaced with 5567.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Trifluperidol

 

Psychiatry related information on Trifluperidol

 

High impact information on Trifluperidol

 

Biological context of Trifluperidol

 

Anatomical context of Trifluperidol

 

Associations of Trifluperidol with other chemical compounds

 

Gene context of Trifluperidol

 

Analytical, diagnostic and therapeutic context of Trifluperidol

References

  1. Neuroleptic malignant syndrome with trifluperidol. Singh, S.P., Giridhar, C., Avasthi, A. The British journal of psychiatry : the journal of mental science. (1989) [Pubmed]
  2. Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells. Kowalski, J., Labuzek, K., Herman, Z.S. Neurochem. Int. (2003) [Pubmed]
  3. Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment. Bischof, F., Melms, A., Fetter, M. Eur. Psychiatry (1999) [Pubmed]
  4. Clinical study with trifluperidol in endogenous depressions [proceedings]. Náhunek, K., Svestka, J., Rodová, A. Activitas nervosa superior. (1976) [Pubmed]
  5. Actions of butyrophenones and other antipsychotic agents at NMDA receptors: relationship with clinical effects and structural considerations. Shim, S.S., Grant, E.R., Singh, S., Gallagher, M.J., Lynch, D.R. Neurochem. Int. (1999) [Pubmed]
  6. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. Coughenour, L.L., Cordon, J.J. J. Pharmacol. Exp. Ther. (1997) [Pubmed]
  7. Effects of beta adrenergic blocking drugs and trifluperidol on intestinal motility and splanchnic nerve activity in cats. Szenohradszky, J., Gibiszer, P.K., Pórszász, J., Gács, E. Acta chirurgica Hungarica. (1983) [Pubmed]
  8. Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Kowalski, J., Labuzek, K., Herman, Z.S. Polish journal of pharmacology. (2004) [Pubmed]
 
WikiGenes - Universities